• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于风险模型和基于风险因素的低剂量计算机断层扫描肺癌筛查策略的益处、危害及成本效益:一项系统评价

Benefits, harms, and cost-effectiveness of risk model-based and risk factor-based low-dose computed tomography screening strategies for lung cancer: a systematic review.

作者信息

Liu Yin, Geng Qingchao, Lin Xin, Feng Chenxi, Qiao Youlin, Zhang Shaokai

机构信息

Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 45008, China.

Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100005, China.

出版信息

BMC Cancer. 2024 Dec 23;24(1):1567. doi: 10.1186/s12885-024-13356-6.

DOI:10.1186/s12885-024-13356-6
PMID:39710662
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665239/
Abstract

BACKGROUND

It has been proposed that risk model-based strategies could serve as viable alternatives to traditional risk factor-based approaches in lung cancer screening; however, there has been no systematic discussion. In this review, we provide an overview of the benefits, harms, and cost-effectiveness of these two strategies in lung cancer screening application, as well as discussing possible future research directions.

METHODS

Following the PRISMA guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, Cochrane libraries, and EMBASE from January 1994 to April 2024. Studies comparing risk model-based and risk factor-based low-dose computed tomography(LDCT) screening strategies for lung cancer were included, with data extracted on study characteristics, screening criteria, and outcomes such as sensitivity, specificity, lung cancer deaths averted, false positive, biopsies, overdiagnosis, radiation-related cancer, and cost-effectiveness measures, et al. RESULTS: A total of 16 fulfilled articles were included, comprising 6 model simulation studies, 9 retrospective cohort studies, and 1 interim analysis of a prospective cohort study. Risk model-based strategies generally demonstrated higher sensitivity, comparable specificity and lower radiation-related harms compared to risk factor-based strategies. However, there were variations in life years gained, quality-adjusted life years gained, lung cancer deaths averted and overdiagnosis cases, highlighting the need for optimal risk threshold determination. Risk model-based strategies showed a potential for greater cost-effectiveness, particularly when tailored to individual risk profiles. Furthermore, subgroup analyses revealed a higher net benefit in women, emphasizing the importance of sex-specific eligibility criteria.

CONCLUSION

Risk model-based LDCT screening strategies present a more sensitive and potentially more efficient approach for lung cancer detection. Future research should explore optimal risk thresholds for broader applicability, with attention to sex-specific criteria and individual risk factor dynamics.

摘要

背景

有人提出,基于风险模型的策略可作为肺癌筛查中传统基于风险因素方法的可行替代方案;然而,尚未有系统的讨论。在本综述中,我们概述了这两种策略在肺癌筛查应用中的益处、危害和成本效益,并讨论了未来可能的研究方向。

方法

遵循PRISMA指南,于1994年1月至2024年4月在PubMed、科学网、Cochrane图书馆和EMBASE上进行了全面的文献检索。纳入了比较基于风险模型和基于风险因素的低剂量计算机断层扫描(LDCT)肺癌筛查策略的研究,并提取了关于研究特征、筛查标准以及敏感性、特异性、避免的肺癌死亡、假阳性、活检、过度诊断、辐射相关癌症和成本效益措施等结果的数据。

结果

共纳入16篇符合要求的文章,包括6篇模型模拟研究、9篇回顾性队列研究和1篇前瞻性队列研究的中期分析。与基于风险因素的策略相比基于风险模型的策略通常表现出更高的敏感性、相当的特异性和更低的辐射相关危害。然而,在获得的生命年、质量调整生命年、避免的肺癌死亡和过度诊断病例方面存在差异,这突出了确定最佳风险阈值的必要性。基于风险模型的策略显示出更大的成本效益潜力,特别是在根据个体风险概况进行调整时。此外,亚组分析显示女性的净效益更高,强调了针对性别的资格标准的重要性。

结论

基于风险模型的LDCT筛查策略为肺癌检测提供了一种更敏感且可能更有效的方法。未来的研究应探索更广泛适用性的最佳风险阈值,同时关注针对性别的标准和个体风险因素动态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0aa/11665239/08e414b70fd5/12885_2024_13356_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0aa/11665239/08e414b70fd5/12885_2024_13356_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0aa/11665239/08e414b70fd5/12885_2024_13356_Fig1_HTML.jpg

相似文献

1
Benefits, harms, and cost-effectiveness of risk model-based and risk factor-based low-dose computed tomography screening strategies for lung cancer: a systematic review.基于风险模型和基于风险因素的低剂量计算机断层扫描肺癌筛查策略的益处、危害及成本效益:一项系统评价
BMC Cancer. 2024 Dec 23;24(1):1567. doi: 10.1186/s12885-024-13356-6.
2
Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.低剂量CT肺癌筛查的益处、危害与经济效率之间的权衡:基于人群的结节管理策略微观模拟分析
BMC Med. 2017 Aug 25;15(1):162. doi: 10.1186/s12916-017-0924-3.
3
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.肺癌低剂量计算机断层扫描筛查的获益与危害评估:美国预防服务工作组的建模研究。
JAMA. 2021 Mar 9;325(10):988-997. doi: 10.1001/jama.2021.1077.
4
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.使用低剂量计算机断层扫描的肺癌筛查策略的成本效益分析:一项系统评价
Appl Health Econ Health Policy. 2016 Aug;14(4):409-418. doi: 10.1007/s40258-016-0226-5.
5
Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.低剂量计算机断层扫描筛查肺癌的成本效益:一项系统文献综述
Eur J Public Health. 2016 Feb;26(1):168-75. doi: 10.1093/eurpub/ckv158. Epub 2015 Sep 14.
6
Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.日本和美国从不吸烟者的低剂量计算机断层扫描肺癌筛查的成本效益和健康影响:一项建模研究。
BMC Pulm Med. 2022 Jan 8;22(1):19. doi: 10.1186/s12890-021-01805-y.
7
Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.低剂量计算机断层扫描在高危人群中的肺癌筛查:系统评价和经济评估。
Health Technol Assess. 2018 Nov;22(69):1-276. doi: 10.3310/hta22690.
8
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.英国肺癌筛查试验:一项关于低剂量计算机断层扫描筛查早期肺癌的试点随机对照试验。
Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.
9
Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.低剂量计算机断层扫描筛查肺癌在重度吸烟者中的成本效益:微观模拟模型研究。
Eur J Cancer. 2020 Aug;135:121-129. doi: 10.1016/j.ejca.2020.05.004. Epub 2020 Jun 18.
10
Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.澳大利亚高危吸烟者低剂量 CT 肺癌筛查的成本效益评估
J Thorac Oncol. 2018 Aug;13(8):1094-1105. doi: 10.1016/j.jtho.2018.04.006. Epub 2018 Apr 22.

引用本文的文献

1
Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study.新型生物标志物组合对早期非小细胞肺癌检测的诊断意义:盲法临床研究结果
Front Oncol. 2025 May 19;15:1508563. doi: 10.3389/fonc.2025.1508563. eCollection 2025.

本文引用的文献

1
Risk-based lung cancer screening in heavy smokers: a benefit-harm and cost-effectiveness modeling study.基于风险的重度吸烟者肺癌筛查:一项获益-危害和成本效益建模研究。
BMC Med. 2024 Feb 19;22(1):73. doi: 10.1186/s12916-024-03292-4.
2
Risk-Adapted Starting Age of Personalized Lung Cancer Screening: A Population-Based, Prospective Cohort Study in China.风险适应的个体化肺癌筛查起始年龄:中国基于人群的前瞻性队列研究。
Chest. 2024 Jun;165(6):1538-1554. doi: 10.1016/j.chest.2024.01.031. Epub 2024 Jan 20.
3
Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland.
瑞士基于风险的低剂量计算机断层扫描筛查肺癌的成本效益。
Int J Cancer. 2024 Feb 15;154(4):636-647. doi: 10.1002/ijc.34746. Epub 2023 Oct 4.
4
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.基于风险模型的肺癌筛查:成本效益分析。
Ann Intern Med. 2023 Mar;176(3):320-332. doi: 10.7326/M22-2216. Epub 2023 Feb 7.
5
Economic impact of using risk models for eligibility selection to the International lung screening Trial.使用风险模型进行入选资格筛选对国际肺癌筛查试验的经济影响。
Lung Cancer. 2023 Feb;176:38-45. doi: 10.1016/j.lungcan.2022.12.011. Epub 2022 Dec 22.
6
Lung cancer screening.肺癌筛查。
Lancet. 2023 Feb 4;401(10374):390-408. doi: 10.1016/S0140-6736(22)01694-4. Epub 2022 Dec 20.
7
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.NCCN 指南®洞察:肺癌筛查,版本 1.2022。
J Natl Compr Canc Netw. 2022 Jul;20(7):754-764. doi: 10.6004/jnccn.2022.0036.
8
Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea.韩国既往吸烟者中用于选择肺癌筛查合格人群的基于风险的预测模型。
Transl Lung Cancer Res. 2021 Dec;10(12):4390-4402. doi: 10.21037/tlcr-21-566.
9
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.USPSTF2013 与 PLCOm2012 肺癌筛查资格标准(国际肺癌筛查试验):前瞻性队列研究的中期分析。
Lancet Oncol. 2022 Jan;23(1):138-148. doi: 10.1016/S1470-2045(21)00590-8. Epub 2021 Dec 11.
10
A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil.一项比较巴西肺癌筛查资格策略的建模分析。
EClinicalMedicine. 2021 Nov 1;42:101176. doi: 10.1016/j.eclinm.2021.101176. eCollection 2021 Dec.